Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples